Cargando…
RP11-616M22.7 recapitulates imatinib resistance in gastrointestinal stromal tumor
Emerging evidence has shown that long non-coding RNAs (lncRNAs) play crucial roles in human cancers. However, systematic characterization of lncRNAs and their roles in gastrointestinal stromal tumor (GIST) therapy have been lacking. We performed high-throughput RNA sequencing (RNA-seq) of 20 GIST an...
Autores principales: | Shao, Yebo, Lian, Shixian, Zheng, Jiajia, Tong, Hanxing, Wang, Jiongyuan, Xu, Jing, Liu, Wenshuai, Hu, Guoxiang, Zhang, Yong, He, Junyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379380/ https://www.ncbi.nlm.nih.gov/pubmed/34458010 http://dx.doi.org/10.1016/j.omtn.2021.05.017 |
Ejemplares similares
-
Imatinib treatment for gastrointestinal stromal tumour (GIST)
por: Lopes, Lisandro F, et al.
Publicado: (2010) -
Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate
por: Din, Omar S, et al.
Publicado: (2008) -
Optimizing Adherence to Adjuvant Imatinib in Gastrointestinal Stromal Tumor
por: Tetzlaff, Eric D., et al.
Publicado: (2013) -
Update on imatinib for gastrointestinal stromal tumors: duration of treatment
por: Linch, Mark, et al.
Publicado: (2013) -
Overcoming heterogenity in imatinib-resistant gastrointestinal stromal tumor
por: Serrano, César, et al.
Publicado: (2019)